-
1
NLRP3 is a BMI-independent mediator of stable COPD
Published 2025-01-01Subjects: Get full text
Article -
2
Successful Treatment of Linear Psoriasis With the IL-17a-Antagonist Ixekizumab: A Case Report
Published 2025-01-01Subjects: Get full text
Article -
3